⌘K

Login Start Free

Home/Filings/4/0001209191-22-018494

4//SEC Filing

Marton Laurence 4

Accession 0001209191-22-018494

CIK 0001574094other

View on SEC.gov Company Profile

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 4:49 PM ET

Size

5.2 KB

Accession

0001209191-22-018494

Insider Transaction Report

Form 4

Period: 2022-03-10

RenovoRx, Inc.RNXT

Marton Laurence

Director

Transactions

Award
Stock Option (right to buy)
2022-03-10+4,582→ 4,582 total
Exercise: $3.17Exp: 2032-03-10→ Common Stock (4,582 underlying)

Footnotes (1)

[F1]The shares subject to the option vest in twelve equal monthly installments beginning on November 1, 2021.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

RenovoRx, Inc.

CIK 0001574094

Entity typeother

Related Parties

1

filerCIK 0001862192

Filing Metadata

Form type: 4
Filed: Mar 13, 8:00 PM ET
Accepted: Mar 14, 4:49 PM ET
Size: 5.2 KB

View on SEC.gov